Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India flag India · Delayed Price · Currency is INR
1,629.70
-77.00 (-4.51%)
Aug 1, 2025, 3:30 PM IST

NSE:SUNPHARMA Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 20212017 - 2021
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2017 - 2021
537,771525,784484,969438,857386,545334,981
Upgrade
Revenue Growth (YoY)
9.28%8.42%10.51%13.53%15.39%2.01%
Upgrade
Cost of Revenue
116,978115,585114,422113,187108,76192,185
Upgrade
Gross Profit
420,793410,200370,547325,670277,784242,796
Upgrade
Selling, General & Admin
103,979100,50995,02583,54973,54469,042
Upgrade
Other Operating Expenses
160,860157,883144,755123,779101,33188,678
Upgrade
Operating Expenses
291,047284,145265,345232,613196,223178,520
Upgrade
Operating Income
129,746126,055105,20293,05881,56064,276
Upgrade
Interest Expense
-2,446-2,314-2,385-1,720-1,274-1,414
Upgrade
Interest & Investment Income
12,97012,97011,2625,3107,6874,672
Upgrade
Earnings From Equity Investments
-143.6-153.5-384.1-479-165.4-123.3
Upgrade
Currency Exchange Gain (Loss)
4,6501,855361.3-1,2611,540236.5
Upgrade
Other Non Operating Income (Expenses)
-60.3620.6546.7756.5735.92,895
Upgrade
EBT Excluding Unusual Items
144,717139,034114,60395,66490,08470,542
Upgrade
Merger & Restructuring Charges
-3,617-3,617-739.5-643.9-563.5-
Upgrade
Gain (Loss) on Sale of Investments
5,1175,117921.9-240.37.7260
Upgrade
Gain (Loss) on Sale of Assets
-164-164-99.775.4347.5138.8
Upgrade
Asset Writedown
-1,586-71.3-1,564-312.5-2,179-155.5
Upgrade
Legal Settlements
-58.2-58.2---1,563-895.6
Upgrade
Other Unusual Items
-9,769-3,104-2,712-1,071-41,657-42,166
Upgrade
Pretax Income
134,870137,368110,49593,60544,64827,870
Upgrade
Income Tax Expense
30,89927,72014,3958,47610,7555,147
Upgrade
Earnings From Continuing Operations
103,971109,64896,10085,12933,89322,724
Upgrade
Minority Interest in Earnings
-250.6-357.1-336.5-393.6-1,1666,315
Upgrade
Net Income
103,721109,29095,76484,73632,72729,038
Upgrade
Net Income to Common
103,721109,29095,76484,73632,72729,038
Upgrade
Net Income Growth
-0.17%14.12%13.01%158.92%12.70%-22.87%
Upgrade
Shares Outstanding (Basic)
2,3982,3992,3992,3992,3992,399
Upgrade
Shares Outstanding (Diluted)
2,3982,3992,3992,3992,3992,399
Upgrade
Shares Change (YoY)
0.00%-----
Upgrade
EPS (Basic)
43.2545.5539.9135.3213.6412.10
Upgrade
EPS (Diluted)
43.2545.5539.9035.3013.6012.10
Upgrade
EPS Growth
-0.14%14.16%13.03%159.56%12.40%-22.89%
Upgrade
Free Cash Flow
-119,43599,33228,73874,89550,002
Upgrade
Free Cash Flow Per Share
-49.7841.4011.9831.2120.84
Upgrade
Dividend Per Share
-16.00013.50011.50010.0007.500
Upgrade
Dividend Growth
-18.52%17.39%15.00%33.33%87.50%
Upgrade
Gross Margin
78.25%78.02%76.41%74.21%71.86%72.48%
Upgrade
Operating Margin
24.13%23.97%21.69%21.20%21.10%19.19%
Upgrade
Profit Margin
19.29%20.79%19.75%19.31%8.47%8.67%
Upgrade
Free Cash Flow Margin
-22.72%20.48%6.55%19.38%14.93%
Upgrade
EBITDA
153,387149,679128,760116,513101,53683,451
Upgrade
EBITDA Margin
28.52%28.47%26.55%26.55%26.27%24.91%
Upgrade
D&A For EBITDA
23,64123,62523,55923,45619,97519,175
Upgrade
EBIT
129,746126,055105,20293,05881,56064,276
Upgrade
EBIT Margin
24.13%23.97%21.69%21.20%21.10%19.19%
Upgrade
Effective Tax Rate
22.91%20.18%13.03%9.05%24.09%18.47%
Upgrade
Revenue as Reported
556,740545,435498,510445,202395,760343,337
Upgrade
Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.